We are live on ! Find out more
TIL icon

Instil Bio
TIL

62 hedge funds and large institutions have $1.35B invested in Instil Bio in 2021 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 17 increasing their positions, 5 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

240% more repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 5

29% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 21

11% more funds holding

Funds holding: 56 → 62 (+6)

0.15% more ownership

Funds ownership: 2.58% → 2.74% (+0.15%)

0% more funds holding in top 10

Funds holding in top 10: 6 → 6 (0)

17% less capital invested

Capital invested by funds: $1.62B → $1.35B (-$271M)

Holders
62
Holders Change
+6
Holders Change %
+10.71%
% of All Funds
1.08%
Holding in Top 10
6
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.1%
New
27
Increased
17
Reduced
5
Closed
21
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$67M
2
AllianceBernstein
AllianceBernstein
Tennessee
+$15.4M
3
BlackRock
BlackRock
New York
+$14.9M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$12.8M
5
SB
Samsara BioCapital
California
+$11M

Top Sellers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
-$30.6M
2
Millennium Management
Millennium Management
New York
-$8.72M
3
SAM
Sectoral Asset Management
Quebec, Canada
-$6.68M
4
HM
HealthCor Management
New York
-$5.02M
5
CAM
Cormorant Asset Management
Massachusetts
-$3.76M
Name Holding Trade Value Shares
Change 		Change in
Stake
Charles Schwab
26
Charles Schwab
California
$2.29M +$2.2M +5,922 New
Bank of New York Mellon
27
Bank of New York Mellon
New York
$2.29M +$1.7M +4,585 +344%
QF
28
QVT Financial
New York
$1.91M +$1.83M +4,932 New
VIA
29
Vident Investment Advisory
Georgia
$1.8M +$1.73M +4,662 New
New York State Common Retirement Fund
30
New York State Common Retirement Fund
New York
$1.18M +$763K +2,058 +208%
N
31
Nuveen
North Carolina
$1.13M +$1.08M +2,922 New
Morgan Stanley
32
Morgan Stanley
New York
$1.1M +$1.01M +2,729 +2,132%
Citadel Advisors
33
Citadel Advisors
Florida
$1.08M -$23.7K -64 -2%
D.E. Shaw & Co
34
D.E. Shaw & Co
New York
$820K +$787K +2,123 New
HS
35
HighVista Strategies
Massachusetts
$801K +$768K +2,072 New
PPA
36
Parametric Portfolio Associates
Washington
$521K +$500K +1,349 New
LCM
37
Legato Capital Management
California
$471K +$452K +1,220 New
California State Teachers Retirement System (CalSTRS)
38
California State Teachers Retirement System (CalSTRS)
California
$465K +$446K +1,203 New
CF
39
CNA Financial
Illinois
$422K +$59.7K +161 +17%
State of Wisconsin Investment Board
40
State of Wisconsin Investment Board
Wisconsin
$340K +$326K +879 New
Victory Capital Management
41
Victory Capital Management
Texas
$327K +$35.6K +96 +13%
SAM
42
Sectoral Asset Management
Quebec, Canada
$326K -$6.68M -18,019 -96%
RhumbLine Advisers
43
RhumbLine Advisers
Massachusetts
$310K +$297K +802 New
Norges Bank
44
Norges Bank
Norway
$290K – – –
ZP
45
Zimmer Partners
New York
$251K – – –
Manulife (Manufacturers Life Insurance)
46
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$218K +$209K +563 New
JP Morgan Chase
47
JP Morgan Chase
New York
$204K +$194K +523 +10,460%
Deutsche Bank
48
Deutsche Bank
Germany
$200K +$192K +517 New
ACM
49
ACT Capital Management
Pennsylvania
$194K +$185K +500 New
MIM
50
MetLife Investment Management
New Jersey
$162K +$156K +420 New
1
2
3 4

TIL Hedge Fund Activity: Q2 2021 in Review

62 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Instil Bio (TIL) for Q2 2021, worth a combined $1.35B — down 17% from $1.62B a quarter earlier.

Buyers outnumbered sellers: 27 funds opened new TIL positions and 21 closed out — a net gain of 6 holders — while 17 added to existing stakes and 5 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $67M. The largest seller was Wellington Management Group, cutting an estimated $30.6M.

  • 62 institutional investors held Instil Bio (TIL) as of Q2 2021, up from 56 in Q1 2021.
  • Funds reported $1.35B of Instil Bio stock for Q2 2021, down 17% quarter-over-quarter.
  • 27 funds opened new Instil Bio positions in Q2 2021 and 21 closed out, a net change of +6 holders.
  • The largest Instil Bio buyer in Q2 2021 was Fidelity Investments, an estimated $67M added.
  • The largest Instil Bio seller in Q2 2021 was Wellington Management Group, an estimated $30.6M sold.

Based on aggregated 13F filings for Q2 2021.